肿瘤患者腹部增强CT的辐射剂量降低:光子计数探测器CT与第二代双源双能量CT的比较
前瞻性纳入70例肿瘤患者,先后使用第二代双源双能量CT和第一代光子计数探测器CT行腹部增强CT,比较辐射剂量与图像质量。光子计数探测器CT的CTDIvol、DLP和SSDE均低于双源双能量CT,SSDE约降低32%,同时血管对比噪声比和信噪比更高、病灶显示更清晰,定性图像噪声两者相似。
要点
- 光子计数探测器CT腹部增强CT的SSDE较第二代双源双能量CT降低约32%。
- 光子计数探测器CT的血管对比噪声比和信噪比显著高于双源双能量CT。
- 光子计数探测器CT的病灶显示清晰度评分显著高于双源双能量CT。
核心结论
- 光子计数探测器CT能在保持与第二代双源双能量CT相似图像质量的同时,以显著降低的辐射剂量完成肿瘤患者腹部CT检查。
研究设计与样本
- 前瞻性研究,纳入70例肿瘤患者(平均年龄66±12岁,女性29例),2021年11月至2022年2月入组,临床指征的腹部增强CT先于第二代双源双能量CT完成,随访时于第一代双源光子计数探测器CT完成。
诊断标准与关键数值
- 光子计数探测器CT与双源双能量CT的CTDIvol分别为7.98±2.56 mGy与14.11±2.92 mGy。
- 光子计数探测器CT与双源双能量CT的DLP分别为393.13±153.55 mGy*cm与693.61±185.76 mGy*cm。
- 光子计数探测器CT与双源双能量CT的SSDE分别为9.98±2.41与14.63±1.63,SSDE约降低32%。
- 光子计数探测器CT的T3D重建血管对比噪声比和信噪比均显著高于双源双能量CT(均p<0.05)。
- 光子计数探测器CT与双源双能量CT的定性图像噪声平均评分均为4分,光子计数探测器CT的病灶显示清晰度评分(Q3强度)显著更高。
临床应用与阅片要点
- 两次扫描使用相同对比剂(Imeron 350,Bracco imaging)和注射泵方案。
- 两种设备均重建3 mm层厚多能图像,卷积核分别为I30f(双源双能量CT)和Br40f(光子计数探测器CT)。
- 光子计数探测器CT使用所有高于20 keV最低能量阈值的计数事件数据(T3D)进行重建。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONAL AND OBJECTIVES: Comparison of radiation dose and image quality in routine abdominal and pelvic contrast-enhanced computed tomography (CECT) between a photon-counting detector CT (PCD-CT) and a dual energy dual source CT (DSCT).
MATERIALS AND METHODS: 70 oncologic patients (mean age 66 ± 12 years, 29 females) were prospectively enrolled between November 2021 and February 2022. Abdominal CECT were clinically indicated and performed first on a 2nd-generation DSCT and at follow-up on a 1st-generation dual-source PCD-CT. The same contrast media (Imeron 350, Bracco imaging) and pump protocol was used for both scans. For both scanners, polychromatic images were reconstructed with 3mm slice thickness and comparable kernel (I30f[DSCT] and Br40f[PCD-CT]); for PCD-CT data from all counted events above the lowest energy threshold at 20 keV ("T3D") were used. Results were compared in terms of radiation dose metrics of CT dose index (CTDIvol), dose length product (DLP) and size-specific dose estimation (SSDE), objective and subjective measurements of image quality were scored by two emergency radiologists including lesion conspicuity.
RESULTS: Median time interval between the scans was 4 months (IQR: 3-6). CNRvessel and SNRvessel of T3D reconstructions from PCD-CT were significantly higher than those of DSCT (all, p < 0.05). Qualitative image noise analysis from PCD-CT and DSCT yielded a mean of 4 each. Lesion conspicuity was rated significantly higher in PCD-CT (Q3 strength) compared to DSCT images. CTDI, DLP and SSDE mean values for PCD-CT and DSCT were 7.98 ± 2.56 mGy vs. 14.11 ± 2.92 mGy, 393.13 ± 153.55 mGy*cm vs. 693.61 ± 185.76 mGy*cm and 9.98 ± 2.41 vs. 14.63 ± 1.63, respectively, translating to a dose reduction of around 32% (SSDE).
CONCLUSION: PCD-CT enables oncologic abdominal CT with a significantly reduced dose while keeping image quality similar to 2nd-generation DSCT.
引用
- Wrazidlo, Walder, Estler, et al. Radiation Dose Reduction in Contrast-Enhanced Abdominal CT: Comparison of Photon-Counting Detector CT with 2nd Generation Dual-Source Dual-Energy CT in an oncologic cohort. Acad Radiol. 2022. PMID: 35760710. doi:10.1016/j.acra.2022.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。